Switching between weight-loss medications This article proposes practical approaches for safe, effective switching between tirzepatide and semaglutide.…
Flu cases rise as data predict ‘record high’ number of urgent repeat prescription requests Experts have urged eligible patients to take up their offer of a free flu vaccine as cases rise across Great Britain.…
Health news round-up: haematology, mental health and pharmacogenomics A weekly summary of important developments in health news that you may have missed.…
Embedding pharmacist-led lipid optimisation clinics in cardiac rehabilitation Cardiology pharmacist Niharika Duggal shares how her integrated care system launched a pilot project in Coventry and Warwickshire to tackle the gap in cardiovascular disease care.…
Government to consult on widening access to take-home naloxone ‘before year end’ In December 2024, UK law was amended to make it legal for pharmacists and pharmacy technicians to provide take-home naloxone kits without a prescription in an effort to widen access.…
A patient’s sex may influence best choice of fracture medication, study finds Researchers found that males demonstrated an association between bisphosphonate use and risk of subsequent fracture, but females did not.…
Seven ways pharmacy can improve outcomes for those impacted by substance use Practical examples of and advice on how pharmacists can improve the care of individuals impacted by substance use. …
Cystic fibrosis combination therapy cuts chronic medication use Researchers reported that patients who were given Kaftrio (elexacaftor-tezacaftor-ivacaftor; Vertex) reduced their use of 4 respiratory therapies after 54 months.…
Health news round-up: the year in health across England, Scotland and Wales A weekly summary of important developments in health news, with summaries from each of the Welsh, Scottish and English chief medical officers’ annual reports.…
All patients should undergo pharmacogenetic testing before being prescribed clopidogrel The UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics has highlighted that a significant proportion of the UK population have lower CYP2C19 enzyme levels, which lower the effectiveness of the antiplatelet drug.…
